Screening properties of the German IQCODE with a two-year time frame in MCI and early Alzheimer's disease.
about
Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care settingInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) settingInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populationsInformant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings.BrainCheck - a very brief tool to detect incipient cognitive decline: optimized case-finding combining patient- and informant-based data.Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.Re-assessing the dimensional structure of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): empirical evidence for a shortened Brazilian version.Whole brain N-acetylaspartate concentration is conserved throughout normal aging.The whole-brain N-acetylaspartate correlates with education in normal adults.The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.A patient cohort on long-term sequelae of sepsis survivors: study protocol of the Mid-German Sepsis CohortPreexisting cognitive impairment in intracerebral hemorrhage.Complainer Profile Identification (CPI): properties of a new questionnaire on subjective cognitive complaints.The Informant Questionnaire on Cognitive Decline in the Elderly individuals in screening mild cognitive impairment with or without functional impairment.Relationship between hospitalization and functional and cognitive impairment in hospitalized older adults patients.
P2860
Q24187059-520BFD8F-C3C7-406A-9AEB-08DB2883B697Q24194747-18DC21B1-5629-4C2A-902B-E19E5DE05965Q24194962-32FC1486-13F4-4288-87CE-1952A664B408Q30240898-54477F52-DEA7-4890-96D6-E5C331EE7593Q30871684-02547E5B-5C18-48C6-8A07-B15BFDDD0DC9Q30871982-EA8CC2F6-E932-489B-AD85-0A0D2F9A33F8Q35727628-34D5EDF9-35BE-465C-8C1E-424781E17E19Q35895046-3D81767D-A5FF-4683-8DF5-A8B471C5F5AAQ36429303-3EE28C57-8318-43EB-AD22-5BD393D84AECQ37053812-9F15B5C7-6953-4C27-80AE-C30767BE54FAQ38609522-551ED1AE-9B1A-4AA6-A74D-FA2EF99F1EBBQ39511130-1E3C26F9-31EF-464B-B49D-B160EB642FEDQ48016824-8623BB1C-38AA-4341-B85F-0301EAEDF584Q50735022-B3C3EB0D-02B9-42A6-B89D-D006D0E6DFF5Q54453144-354060F4-C994-41B0-A0A6-B18A0FE867D0
P2860
Screening properties of the German IQCODE with a two-year time frame in MCI and early Alzheimer's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Screening properties of the Ge ...... and early Alzheimer's disease.
@en
Screening properties of the Ge ...... and early Alzheimer's disease.
@nl
type
label
Screening properties of the Ge ...... and early Alzheimer's disease.
@en
Screening properties of the Ge ...... and early Alzheimer's disease.
@nl
prefLabel
Screening properties of the Ge ...... and early Alzheimer's disease.
@en
Screening properties of the Ge ...... and early Alzheimer's disease.
@nl
P2093
P2860
P1476
Screening properties of the Ge ...... and early Alzheimer's disease.
@en
P2093
Andreas U Monsch
Manfred Berres
Michael M Ehrensperger
P2860
P304
P356
10.1017/S1041610209990962
P577
2009-09-14T00:00:00Z